This Report to the Industry provides background on the issue of pharmaceutical benefit delivery, reimbursement, and management in California workers’ compensation. The analysis reviews past studies by CWCI and other research organizations that compare the California system to other programs, examines the current role and potential savings from PBMs, and outlines factors that are likely to affect the cost and delivery of pharmaceuticals to injured workers in the future.
Pharmaceutical Cost Management in California Workers’ Compensation
